| 000 | 01780 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515111436.0 | ||
| 264 | 0 | _c20080327 | |
| 008 | 200803s 0 0 eng d | ||
| 022 | _a1600-0455 | ||
| 024 | 7 |
_a10.1080/02841850701736263 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchmitz, S A | |
| 245 | 0 | 0 |
_aWhite matter brain lesions in midlife familial hypercholesterolemic patients at 3-Tesla magnetic resonance imaging. _h[electronic resource] |
| 260 |
_bActa radiologica (Stockholm, Sweden : 1987) _cMar 2008 |
||
| 300 |
_a184-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 |
_aBrain _xpathology |
| 650 | 0 | 4 |
_aBrain Diseases _xdiagnosis |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aContrast Media _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGadolinium DTPA |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aHyperlipoproteinemia Type II _xblood |
| 650 | 0 | 4 |
_aImage Enhancement _xmethods |
| 650 | 0 | 4 |
_aMagnetic Resonance Imaging _xinstrumentation |
| 650 | 0 | 4 | _aMagnetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aObserver Variation |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aO'Regan, D P | |
| 700 | 1 | _aFitzpatrick, J | |
| 700 | 1 | _aNeuwirth, C | |
| 700 | 1 | _aPotter, E | |
| 700 | 1 | _aTosi, I | |
| 700 | 1 | _aHajnal, J V | |
| 700 | 1 | _aNaoumova, R P | |
| 773 | 0 |
_tActa radiologica (Stockholm, Sweden : 1987) _gvol. 49 _gno. 2 _gp. 184-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/02841850701736263 _zAvailable from publisher's website |
| 999 |
_c17803770 _d17803770 |
||